Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study
Authors:
Open Access
- 6 April 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14
Abstract
Botulinum toxin type A (BoNT-A) is the treatment of choice for focal spasticity, with a concomitant effect on pain reduction and improvement of quality of life (QoL). Current evidence of its efficacy is based mainly on post stroke spasticity. This study aims to clarify the role of BoNT-A in the context of non-stroke spasticity (NSS). We enrolled 86 patients affected by multiple sclerosis, spinal cord injury, and traumatic brain injury with clinical indication to perform BoNT-A treatment. Subjects were evaluated before injection and after 1, 3, and 6 months. At every visit, spasticity severity using the modified Ashworth scale, pain using the numeric rating scale, QoL using the Euro Qol Group EQ-5D-5L, and the perceived treatment effect using the Global Assessment of Efficacy scale were recorded. In our population BoNT-A demonstrated to have a significant effect in improving all the outcome variables, with different effect persistence over time in relation to the diagnosis and the number of treated sites. Our results support BoNT-A as a modifier of the disability condition and suggest its implementation in the treatment of NSS, delivering a possible starting point to generate diagnosis-specific follow-up programs.Clinical trial identifier: NCT04673240.Keywords
Funding Information
- Ipsen
This publication has 49 references indexed in Scilit:
- Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practiceExpert Review of Neurotherapeutics, 2013
- The Effect of Neural Lesion Type on Botulinum Toxin Dosage: A Retrospective Chart ReviewPM&R, 2013
- Spasticity: pathophysiology, evaluation and managementPractical Neurology, 2012
- Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)Arthritis Care & Research, 2011
- Contribution of impaired mobility and general symptoms to the burden of multiple sclerosisAdvances in Therapy, 2009
- European consensus table on the use of botulinum toxin type A in adult spasticityJournal of Rehabilitation Medicine, 2009
- Spasticity Experience Domains in Persons With Spinal Cord InjuryArchives of Physical Medicine and Rehabilitation, 2007
- Spasticity-assessment: a reviewSpinal Cord, 2006
- Spasticity after spinal cord injurySpinal Cord, 2005
- Pathophysiology of spastic paresis. II: Emergence of muscle overactivityMuscle & Nerve, 2005